Detalhe da pesquisa
1.
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma.
Nature
; 594(7863): 418-423, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33953400
2.
Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study.
Diabetes Obes Metab
; 21(11): 2429-2439, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31264757
3.
Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline.
BMJ Open Diabetes Res Care
; 10(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35042751
4.
Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study.
BMJ Open Diabetes Res Care
; 9(1)2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34172436
5.
Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trial.
Lung Cancer
; 135: 66-72, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31447004
6.
Occurrence of shigellosis in the young and elderly in rural China: results of a 12-month population-based surveillance study.
Am J Trop Med Hyg
; 73(2): 416-22, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16103614
7.
The burden of diarrhoea, shigellosis, and cholera in North Jakarta, Indonesia: findings from 24 months surveillance.
BMC Infect Dis
; 5: 89, 2005 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16242013